Manoj Chelvanambi

1.9k total citations · 2 hit papers
15 papers, 858 citations indexed

About

Manoj Chelvanambi is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Manoj Chelvanambi has authored 15 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Manoj Chelvanambi's work include Cancer Immunotherapy and Biomarkers (7 papers), interferon and immune responses (4 papers) and Gut microbiota and health (4 papers). Manoj Chelvanambi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), interferon and immune responses (4 papers) and Gut microbiota and health (4 papers). Manoj Chelvanambi collaborates with scholars based in United States, France and Australia. Manoj Chelvanambi's co-authors include Walter J. Storkus, J Filderman, Jennifer A. Wargo, Afsaneh Amouzegar, Jason J. Luke, Elizabeth M. Park, Neal Bhutiani, Guido Kroemer, Laurence Zitvogel and Jennifer L. Taylor and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Manoj Chelvanambi

15 papers receiving 846 citations

Hit Papers

Targeting the gut and tumor microbiota in cancer 2021 2026 2022 2024 2022 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting the gut and tumor microbiota in cancer
    2022 329 citations Elizabeth M. Park, Manoj Chelvanambi et al. Nature Medicine profile →
  2. STING Agonists as Cancer Therapeutics
    2021 286 citations Afsaneh Amouzegar, Manoj Chelvanambi et al. Cancers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manoj Chelvanambi United States 8 467 398 349 124 65 15 858
Meriem Messaoudene Canada 17 593 1.3× 410 1.0× 628 1.8× 124 1.0× 59 0.9× 36 1.2k
Romina E. Araya Argentina 8 341 0.7× 292 0.7× 269 0.8× 75 0.6× 36 0.6× 8 734
Demi Sandel United States 4 294 0.6× 455 1.1× 339 1.0× 51 0.4× 76 1.2× 5 837
Mireia Uribe‐Herranz United States 11 324 0.7× 506 1.3× 688 2.0× 102 0.8× 36 0.6× 24 1.0k
Stefano Pierini United States 9 171 0.4× 363 0.9× 294 0.8× 97 0.8× 47 0.7× 17 588
Tanya Fainsod-Levi Israel 7 314 0.7× 347 0.9× 320 0.9× 44 0.4× 71 1.1× 7 844
Zvi G. Fridlender United States 14 508 1.1× 222 0.6× 367 1.1× 41 0.3× 70 1.1× 19 831
Sarah B. Johnson United States 3 191 0.4× 328 0.8× 255 0.7× 78 0.6× 31 0.5× 5 524
Iris Mimpen Netherlands 3 211 0.5× 309 0.8× 372 1.1× 58 0.5× 53 0.8× 3 611

Countries citing papers authored by Manoj Chelvanambi

Since Specialization
Citations

This map shows the geographic impact of Manoj Chelvanambi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manoj Chelvanambi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manoj Chelvanambi more than expected).

Fields of papers citing papers by Manoj Chelvanambi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manoj Chelvanambi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manoj Chelvanambi. The network helps show where Manoj Chelvanambi may publish in the future.

Co-authorship network of co-authors of Manoj Chelvanambi

This figure shows the co-authorship network connecting the top 25 collaborators of Manoj Chelvanambi. A scholar is included among the top collaborators of Manoj Chelvanambi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manoj Chelvanambi. Manoj Chelvanambi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Chelvanambi, Manoj, Ashish Damania, Sarah B. Johnson, et al.. (2024). Abstract 6691: Engraftment as a determinant of response in fecal microbiome transplantation interventions for immunotherapy in melanoma. Cancer Research. 84(6_Supplement). 6691–6691. 1 indexed citations
2.
Seo, Yongwoo David, et al.. (2023). Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment. Cancers. 15(3). 777–777. 12 indexed citations
3.
Cascone, Tina, Manoj Chelvanambi, & Jennifer A. Wargo. (2022). Immunotherapy response-associated Akkermansia: canary in a coal mine?. Trends in Immunology. 43(5). 337–339. 7 indexed citations
4.
Park, Elizabeth M., Manoj Chelvanambi, Neal Bhutiani, et al.. (2022). Targeting the gut and tumor microbiota in cancer. Nature Medicine. 28(4). 690–703. 329 indexed citations breakdown →
5.
Nassif, Elise F., Manoj Chelvanambi, Lili Chen, et al.. (2022). Identifying gut microbial signatures associated with B cells and tertiary lymphoid structures (TLS) in the tumor microenvironment (TME) in response to immune checkpoint blockade (ICB).. Journal of Clinical Oncology. 40(16_suppl). 2511–2511. 1 indexed citations
6.
White, Michael G., Christopher P. Vellano, Miles C. Andrews, et al.. (2022). Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.. Journal of Clinical Oncology. 40(16_suppl). 9523–9523. 1 indexed citations
7.
Zelazowska, Monika A., Somnath Paul, Joshua B. Plummer, et al.. (2022). 988 B-cell receptor (BCR) repertoire and antibody recognition analysis of melanoma patients treated with neoadjuvant immune checkpoint blockade (ICB). Regular and Young Investigator Award Abstracts. A1030–A1030. 1 indexed citations
8.
Chelvanambi, Manoj, et al.. (2021). Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation. Frontiers in Immunology. 12. 629519–629519. 10 indexed citations
9.
Filderman, J, et al.. (2021). STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development. Frontiers in Immunology. 12. 690105–690105. 29 indexed citations
10.
Powell, Matthew A., Rigel J. Kishton, Manoj Chelvanambi, et al.. (2021). Mechanistic Investigation of Site-specific DNA Methylating Agents Targeting Breast Cancer Cells. Journal of Medicinal Chemistry. 64(17). 12651–12669. 1 indexed citations
11.
Amouzegar, Afsaneh, Manoj Chelvanambi, J Filderman, Walter J. Storkus, & Jason J. Luke. (2021). STING Agonists as Cancer Therapeutics. Cancers. 13(11). 2695–2695. 286 indexed citations breakdown →
12.
Chelvanambi, Manoj, Ronald J. Fecek, Jennifer L. Taylor, & Walter J. Storkus. (2021). STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. Journal for ImmunoTherapy of Cancer. 9(2). e001906–e001906. 143 indexed citations
13.
Chelvanambi, Manoj, Ronald J. Fecek, Jennifer L. Taylor, & Walter J. Storkus. (2020). 602 STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. SHILAP Revista de lepidopterología. A359.2–A360. 6 indexed citations
14.
Chelvanambi, Manoj, Aliyah M. Weinstein, & Walter J. Storkus. (2020). IL-36 Signaling in the Tumor Microenvironment. Advances in experimental medicine and biology. 1240. 95–110. 16 indexed citations
15.
Ludwig, Sonja, Chang‐Sook Hong, Beatrice M. Razzo, et al.. (2019). Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinoma. Cancer Immunology Immunotherapy. 68(7). 1133–1141. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meriem Messaoudene Breakdown of academic impact, for papers by Romina E. Araya Breakdown of academic impact, for papers by Demi Sandel Breakdown of academic impact, for papers by Mireia Uribe‐Herranz Breakdown of academic impact, for papers by Stefano Pierini Breakdown of academic impact, for papers by Tanya Fainsod-Levi Breakdown of academic impact, for papers by Zvi G. Fridlender Breakdown of academic impact, for papers by Sarah B. Johnson Breakdown of academic impact, for papers by Iris Mimpen
Rankless by CCL
2026